News | February 21, 2022
SEBI approves IPO plans of PharmEasy and Wellness Forever Medicare
The companies plan to use the proceeds to retire debt and expand operations
The companies plan to use the proceeds to retire debt and expand operations
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
FY26 revenue rises 17% to Rs. 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
